Neuland Laboratories Limited was established over 30 years ago and today is a publicly listed company headquartered in Hyderabad, India. Neuland is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry for chemistry related services. Our main business is manufacturing of API's and advanced intermediates from our FDA approved facilities and we are end-to-end solution provider for the pharmaceutical industry for chemistry related services from synthesis of library compounds to supply NCEs and intermediates at various clinical phases up to commercial scale. Our core competence lies in the application of strong process chemistry to manufacturing in regulatory, which is supported by a strong force of more than 1000 employees.
For over 30 years, Neuland has been at the forefront of facilitating and accelerating drug development and cGMP manufacturing of APIs. The Company’s technical and scientific teams provide reliable solutions and services to the global pharmaceutical industry.
The company's strength lies in its ability to partner with companies (over 700 customers spread across the globe) from early stage and throughout the life cycle of the products, with speed and efficiency in order to maintain their competitiveness.
Neuland is a no-compromise, pharmaceutical services provider, offering worldwide compliant manufacturing facilities to its customers which it guarantees not to compete with in finished product.
Neuland has meaningful footprints in several countries with more than 80% of the revenues accounted for by exports. US and Europe are our key markets, accounting for 70 % of total exports.
The Company has filed 45 DMFs with the USFDA and over 400 DMFs with various health authorities in Europe, Canada, Japan, Korea and Australia.
Our Top Ten Products
The Company is present in eight major therapeutic categories including cardiovascular, central nervous systems, anti-invectives, anti-asthmatics, anti-fungal, anti-ulcerants and anti-spasmodic.
The top 10 products of the Company are:
- Ciprofloxacin HCl
- Ranitidine HCl
- Enalapril Maleate
- Sotalol HCl
- Ipratropium Bromidet
- Over 30 years of successful presence in the pharmaceutical industry
- Focused on manufacture of APIs, Custom Manufacturing Solutions
- 2 US FDA, EDQM inspected manufacturing facilities
- Over 400 DMFs worldwide; with a presence in over 85 countries
- 40,000 sq. ft. state-of-the-art R&D facility at Hyderabad
- More than 1000 employees
- Approximately 200 scientists working in R & D with 31 Ph.Ds
- Listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE)
- US FDA, TGA, EDQM, German Health Authority, ANVISA, ISO 14001, ISO 27001 and OHSAS 18001 Certified
- Collaboration with MAPIC India Pvt. Ltd.
In order to better service customers in Japan and USA, Neuland has incorporated the above subsidiaries to support the full range of the Company’s products and services including:
- Active Pharmaceutical Ingredients
- Contract Research
- Custom Manufacturing Solutions